Dermatology: the ‘added value’ specialty

Abstract

drome/toxic epidermal necrolysis: an unmet need. J Am Acad Dermatol 2018; 79:e87–e88. 8 Tsai TY, Huang IH, Chao YC et al. Treating toxic epidermal necrolysis with systemic immunomodulating therapies: a systematic review and network meta-analysis. J Am Acad Dermatol 2021; 84:390–7. 9 Torres-Navarro I, Briz-Redon A, Botella-Estrada R. Systemic therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a SCORTEN-based systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2021; 35:159–71. 10 Wang CW, Yang LY, Chen CB et al. Randomized, controlled trial of TNF-a antagonist in CTL-mediated severe cutaneous adverse reactions. J Clin Invest 2018; 128:985–96.